1. Cirrhose et carcinome hépatocellulaire : diagnostic et suivi biologique
    Patrick Pham et al, 2017, Revue Francophone des Laboratoires CrossRef
  2. Quantitative mass spectrometric analysis of hepatocellular carcinoma biomarker alpha-fetoprotein
    Chen-Chun Chen et al, 2023, RSC Chemical Biology CrossRef
  3. An AgPd NP-based lateral flow immunoassay for simultaneous detection of glycocholic acid and alpha-fetoprotein
    Shilin Jiang et al, 2024, Analytical Methods CrossRef
  4. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
    Pei-Pei Song, 2016, World Journal of Gastroenterology CrossRef
  5. Serum levels of anti‑sperm‑associated antigen 9 antibody are elevated in patients with hepatocellular carcinoma
    Biqiong Ren et al, 2017, Oncology Letters CrossRef
  6. The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
    Famei Qi et al, 2020, Journal of Clinical Laboratory Analysis CrossRef
  7. Labordiagnostik bei primärem Leberzellkarzinom
    J.F. Schlaak, 2014, Der Gastroenterologe CrossRef
  8. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model
    Abdallah H. Fathy et al, 2017, Canadian Journal of Physiology and Pharmacology CrossRef
  9. Alpha-fetoprotein-L3 in hepatocellular carcinoma: A meta-analysis
    Xiaoyan Yi et al, 2013, Clinica Chimica Acta CrossRef
  10. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
    Sang Joon Park et al, 2017, Medicine CrossRef
  11. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma
    Jiuwei Cui et al, 2014, International Journal of Cancer CrossRef
  12. Novel biomarkers in hepatocellular carcinoma
    Felice De Stefano et al, 2018, Digestive and Liver Disease CrossRef
  13. The correlation between P53 and COX-2 expression and the pathological alteration in hepatocellular carcinoma
    Moustafa A. Sakr et al, 2022, Egyptian Journal of Medical Human Genetics CrossRef
  14. Remarkable alpha-fetoprotein elevation and pseudo-infarction of cirrhotic liver: case report
    Maged Tharwat Elghannam et al, 2024, Exploration of Digestive Diseases CrossRef
  15. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis
    Kerstin Schütte, 2014, World Journal of Hepatology CrossRef
  16. An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma
    Swathy S. Samban et al, 2023, Molecular Biotechnology CrossRef
  17. Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment
    Kerstin Schütte et al, 2014, Gastrointestinal Tumors CrossRef
  18. Diagnostic and therapeutic management of hepatocellular carcinoma
    Francesco Bellissimo, 2015, World Journal of Gastroenterology CrossRef
  19. Protein Biomarkers in the Management of Hepatocellular Carcinoma: Novel Combinatory Approaches
    Philip Johnson et al, 2016, Hepatocellular Carcinoma CrossRef

  20. cccDNA Maintenance in Chronic Hepatitis B – Targeting the Matrix of Viral Replication


    Maura Dandri et al, 2020, Infection and Drug Resistance CrossRef